The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Trump says Senate hearing on DNI nominee is cancelled until US attorney replacement confirmed
Trump DNI pick braces for Senate grilling as temporary stand-in fuels Dem pressure
5 chilling details from the alleged White House attack plot tied to UFC event
Canadian tourism to US begins to rebound after 51st state, tariffs debacle
Netanyahu’s relationship with Trump becomes baggage in reelection campaign
Trump wins two, loses one: Georgia billionaire delivers rare blow to endorsement machine
Texas plane crash leaves one dead, more injured after business jet catches fire on highway
GOP Gov DeWine urges Ohio to abolish the death penalty, says it is no longer a deterrent
Dems pick potential successor to DC’s congressional delegate after decades-long incumbency
State of play: What to know about potential socialist showdown between Trump and DC mayor as votes pour in
DC Guard shooting suspect stares down death penalty in first court appearance
Trump’s endorsement fails to save MAGA candidate as billionaire advances in key governor race
FDNY deploys 140+ personnel to JFK after Delta flight reported with flat tires on approach to landing
Look: World Cup Fans Visiting for the First Time Fall in Love with America, Go Viral on Blessings We Take for Granted
Trump-backed ‘McCongressman’ wins Oklahoma Senate primary, vows push for stalled SAVE Act
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Trump says Senate hearing on DNI nominee is cancelled until US attorney replacement confirmed
Trump DNI pick braces for Senate grilling as temporary stand-in fuels Dem pressure
5 chilling details from the alleged White House attack plot tied to UFC event
Canadian tourism to US begins to rebound after 51st state, tariffs debacle
Netanyahu’s relationship with Trump becomes baggage in reelection campaign
Trump wins two, loses one: Georgia billionaire delivers rare blow to endorsement machine
Texas plane crash leaves one dead, more injured after business jet catches fire on highway
GOP Gov DeWine urges Ohio to abolish the death penalty, says it is no longer a deterrent
Dems pick potential successor to DC’s congressional delegate after decades-long incumbency
State of play: What to know about potential socialist showdown between Trump and DC mayor as votes pour in
DC Guard shooting suspect stares down death penalty in first court appearance
Trump’s endorsement fails to save MAGA candidate as billionaire advances in key governor race
FDNY deploys 140+ personnel to JFK after Delta flight reported with flat tires on approach to landing
Look: World Cup Fans Visiting for the First Time Fall in Love with America, Go Viral on Blessings We Take for Granted
Trump-backed ‘McCongressman’ wins Oklahoma Senate primary, vows push for stalled SAVE Act
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
